Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
PONOU PONO CAPITAL CORP UNIT 1 CL A & 3/4 WT EXP
11.1500.0000.00%
Close
02/03 16:00 ET
High
0.000
Open
0.000
Turnover
0.00
Low
0.000
Pre Close
11.150
Volume
0.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
PONOU Stock Trading Resumes
PONOU Stock Trading Halted, Volatility Trading Pause
Pono Capital (NASDAQ:PONOU) Stock Price Up 2.1%
Pono Capital Corp. (NASDAQ:PONOU – Get Rating)'s share price was up 2.1% during mid-day trading on Wednesday . The stock traded as high as $10.48 and last traded at $10.45. Approximately 1,078 shares
Pono Capital (NASDAQ:PONOU) Shares Down 0.7%
Pono Capital Corp. (NASDAQ:PONOU – Get Rating) shares traded down 0.7% during trading on Tuesday . The company traded as low as $10.10 and last traded at $10.10. 200 shares traded hands during tradin
Pono Capital Corp Announces Termination of Merger Agreement with Benuvia, Inc.
Globe Newswire 10-Aug-2022 5:25 PMHonolulu, Hawaii, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pono Capital Corp (NASDAQ:PONO) (the "Company" or "Pono"), a special purpose acquisition company, announced tod
Pono Capital Corp Confirms Funding to Extend Period to Consummate Initial Business Combination
Globe Newswire 10-Aug-2022 5:25 PMHonolulu, Hawaii, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pono Capital Corp (the "Company") (NASDAQ:PONO), a special purpose acquisition company, today announced that Me
Pono Capital Corp Combination Partner Benuvia Receives Approval From DEA To Manufacture Psychedelic Active Pharmaceutical Ingredients including Psilocybin, MDMA And DMT
With this approval, Benuvia has begun focusing on four primary psychedelic ingredients: Psilocybin, N,N-Dimethyl-5-Methoxy-Tryptamine (5-MeO DMT), Dimethyltryptamine (DMT), and 3,4-Methylenedioxymetha
Cannabinoid Drugmaker Benuvia to Go Public Via SPAC Merger With Pono Capital
07:27 AM EDT, 03/18/2022 (MT Newswires) -- Cannabinoid drugmaker Benuvia and blank-check firm Pono Capital (PONO, PONOU) said Friday they have entered into a definitive merger agreement to facilitate
Benuvia To Go Public Via SPAC Deal With Pono Capital, Deal Valued At $440M
Benuvia, a leading drug developer focused on pharmaceutical cannabinoids has entered into a definitive business combination agreement with Pono Capital Corp (NASDAQ:PONO)The transaction implies a comb
News On Pono Capital Corp. (PONOU) Now Under PONO
*DJ News On Pono Capital Corp. (PONOU) Now Under PONO (END) Dow Jones Newswires October 06, 2021 17:08 ET (21:08 GMT) Copyright (c) 2021 Dow Jones & Company, Inc.
